Self-Assembling Amphiphilic PROTACs: A Chemical Strategy for Improved EGFR-Targeted Protein Degradation

  • J Med Chem. 2026 Jun 25;69(12):14866-14884. doi: 10.1021/acs.jmedchem.6c00971.
Junhui Ma  1  2 Lei Fang  2 Yu Wu  2 Hui Jiao  2 Guangya Xiang  2  3  4 Xiang Ma  2  3
Affiliations
  • 1. School of Pharmacy, Henan University, Kaifeng 475004, China.
  • 2. School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • 3. School of Pharmacy, Tongren Polytechnic College, Tongren, Guizhou 554300, China.
  • 4. The Higher Education Edible and Medicinal Fungi Engineering Research Center of Guizhou Province, Tongren, Guizhou 554300, China.
Abstract

Proteolysis-targeting chimeras (PROTACs) are attractive targeted protein degradation modalities, while their clinical advancement is limited by high molecular weight, suboptimal bioavailability, low cellular permeability, and unsatisfactory in vivo efficacy. Herein, we developed a self-assembled nanoparticle system (PRO NPs) constructed from amphiphilic PROTACs. Owing to their intrinsic amphiphilicity, PRO NPs can spontaneously assemble into stable nanoparticles without external excipients, simplifying fabrication and alleviating carrier-associated toxicity. Compared with the free EGFR-targeting PROTAC, PRO NPs exhibited enhanced aqueous solubility and efficient EGFR degradation in HCC827 cells. In vivo, PRO NPs functionalized with hyaluronic acid (HA) through electrostatic adsorption could actively accumulate at tumor sites via CD44-mediated targeting, exerting potent antitumor efficacy (TGI = 76.8%) with reduced systemic toxicity. Collectively, these findings provide novel insights into nano-PROTAC design and a promising strategy for the development of targeted protein degradation therapies.

Products